OOIR: Observatory of International Research

Papers

(The TQCC of Drug Testing and Analysis is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Performance evaluation of handheld Raman spectroscopy for cocaine detection in forensic case samples	41
The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent‐4en and but‐3en analogues including MDMB‐4en‐PINACA	39
Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations	37
Can dried blood spots (DBS) contribute to conducting comprehensive SARS‐CoV‐2 antibody tests?	33
Rapid and robust on‐scene detection of cocaine in street samples using a handheld near‐infrared spectrometer and machine learning algorithms	33
Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing?	33
Metonitazene in the United States—Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry	32
Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)	30
Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis	29
Shape matters: The application of activity‐based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug‐infused papers seiz	28
A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations	28
Electrochemical profiling and liquid chromatography–mass spectrometry characterization of synthetic cathinones: From methodology to detection in forensic samples	28
Identification of AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 in seized materials after the class‐wide ban of synthetic cannabinoids in China	28
The metabolism of the synthetic cannabinoids ADB‐BUTINACA and ADB‐4en‐PINACA and their detection in forensic toxicology casework and infused papers seized in prisons	28
A review of nicotine‐containing electronic cigarettes—Trends in use, effects, contents, labelling accuracy and detection methods	27
Longitudinal evaluation of multiple biomarkers for the detection of testosterone gel administration in women with normal menstrual cycle	27
In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis	27
The roles of phosphatidylethanol, ethyl glucuronide, and ethyl sulfate in identifying alcohol consumption among participants in professionals health programs	27
Sports drug testing and the athletes' exposome	27
Discrimination of legal and illegal Cannabis spp. according to European legislation using near infrared spectroscopy and chemometrics	26
No pain, just gain: Painless, easy, and fast dried blood spot collection from fingertip and upper arm in doping control	25
Simultaneous testing for anabolic steroids in human hair specimens collected from various anatomic locations has several advantages when compared with the standard head hair analysis	24
Urinary steroid profile in relation to the menstrual cycle	23
Fluctuations in hematological athlete biological passport biomarkers in relation to the menstrual cycle	23
Elimination profiles of microdosed ostarine mimicking contaminated products ingestion	23

Analysis of supplements available to UK consumers purporting to contain selective androgen receptor modulators	22
Analysis of bitter orange dietary supplements for natural and synthetic phenethylamines by LC–MS/MS	22
Annual banned‐substance review: Analytical approaches in human sports drug testing 2019/2020	22
Stability of synthetic cathinones in clinical and forensic toxicological analysis—Where are we now?	21
Cumyl‐CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain	21
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists	21
Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses	21
Development and validation of liquid chromatography‐tandem mass spectrometry targeted screening of 16 fentanyl analogs and U‐47700 in hair: Application to 137 authentic samples	20
Improved detection methods significantly increase the detection window for EPO microdoses	20
Do dried blood spots have the potential to support result management processes in routine sports drug testing?—Part 2: Proactive sampling for follow‐up investigations concerning atypical or adverse an	19
A calibration friendly approach to identify drugs of abuse mixtures with a portable near‐infrared analyzer	19
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of bindin	19
What's in fake ‘Xanax’?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets	19
A duplex qPCR assay for human erythropoietin (EPO) transgene to control gene doping in horses	19
Stability and detectability of testosterone esters in dried blood spots after intramuscular injections	19
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of bindin	18
Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood	18
Organ‐on‐a‐chip: Determine feasibility of a human liver microphysiological model to assess long‐term steroid metabolites in sports drug testing	18
Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)	18
Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use	18
Large‐scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons	17
Annual banned‐substance review: Analytical approaches in human sports drug testing 2020/2021	17
Adulterants in selected dietary supplements and their detection methods	17
Fully automated dried blood spot sample handling and extraction for serological testing of SARS‐CoV‐2 antibodies	17
Analytical characterization of “etonitazepyne,” a new pyrrolidinyl‐containing 2‐benzylbenzimidazole opioid sold online	17
Testing for GW501516 (cardarine) in human hair using LC/MS–MS and confirmation by LC/HRMS	17
Hair analysis can support the follow‐up addiction care after acute New Psychoactive Substances intoxication: Illustration by two cases	16
NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches	16
In vitro activity profiling of Cumyl‐PEGACLONE variants at the CB₁ receptor: Fluorination versus isomer exploration	16
Metabolite elucidation of 2‐fluoro‐deschloroketamine (2F‐DCK) using molecular networking across three complementary in vitro and in vivo models	15
Searching for new long‐term urinary metabolites of metenolone and drostanolone using gas chromatography–mass spectrometry with a focus on non‐hydrolysed sulfates	15
A fast screening method for the detection of CERA in dried blood spots	15
The influence of chemical modifications on the fragmentation behavior of fentanyl and fentanyl‐related compounds in electrospray ionization tandem mass spectrometry	15
Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4‐methylendioxy‐N‐methylamphetamine (MDMA) in seized street drug samples from southern Germany	15
Identification of S22 (ostarine) in human nails and hair using LC‐HRMS. Application to two authentic cases	15
Hexahydrocannabinol and closely related semi‐synthetic cannabinoids: A comprehensive review	15
Analysis of six different homologues of phosphatidylethanol from dried blood spots using liquid chromatography–tandem mass spectrometry	15
Development of a new GC–MS/MS method for the determination of metformin in human hair	15
Single‐dose administration of clenbuterol is detectable in dried blood spots	15
Metabolic profiling of deschloro‐N‐ethyl‐ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high‐resolution accurate mass spectrometry	15
New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA	15
Development of a multi‐residue high‐throughput UHPLC–MS/MS method for routine monitoring of SARM compounds in equine and bovine blood	15
Analysis of cobalt for human sports drug testing purposes using ICP‐ and LC‐ICP‐MS	15
Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry	15
Analytical and medico‐legal problems linked to the presence of delta‐8‐tetrahydrocannabinol (delta‐8‐THC): Results from urine drug testing in Sweden	15
A validated method for the simultaneous quantification of cannabidiol, Δ⁹‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabid	14
Phase I metabolites (organic acids) of gamma‐hydroxybutyric acid–validated quantification using GC–MS and description of endogenous concentration ranges	14
High‐throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction	14
Metabolic studies of hypoxia‐inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control	14
From JWH‐018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day	14

Increase in drugs‐of‐abuse findings in post‐mortem toxicology due to COVID‐19 restrictions—First observations in Finland	14
An infrared spectroscopic approach to characterise white powders, easily applicable in the context of drug checking, drug prevention and on‐site analysis	14
Evaluation of longitudinal steroid profiling with the ADAMS adaptive model for detection of transdermal, intramuscular, and subcutaneous testosterone administration	14
Detection of the selective androgen receptor modulator GSK2881078 and metabolites in urine and hair after single oral administration	14
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of bindin	14
Retrospective analysis of new psychoactive substances in blood samples of German drivers suspected of driving under the influence of drugs	14
Applying metabolomics to detect growth hormone administration in athletes: Proof of concept	14
Metabolomics in clinical and forensic toxicology, sports anti‐doping and veterinary residues	14
Optimizing detection of erythropoietin receptor agonists from dried blood spots for anti‐doping application	14
Paper spray mass spectrometry – A potential complementary technique for the detection of polar compounds in sports drug testing	13
Changes in blood parameters after intramuscular testosterone ester injections – Implications for anti‐doping	13
Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration	13
Urinary detection of rapid‐acting insulin analogs in healthy humans	13
Comparison of commercial surface‐enhanced Raman spectroscopy substrates for the analysis of cocaine	13
Immature reticulocytes are sensitive and specific to low‐dose erythropoietin treatment at sea level and altitude	13
New qualitative analysis strategy for illicit drugs using Raman spectroscopy and characteristic peaks method	13
On‐site forensic analysis of colored seized materials: Detection of brown heroin and MDMA‐tablets by a portable NIR spectrometer	13
Automated high‐throughput analysis of tramadol and O‐desmethyltramadol in dried blood spots	12
Dried blood spots for anti‐doping: Why just going volumetric may not be sufficient	12
Evaluation of epiandrosterone as a long‐term marker of testosterone use	12
Intoxication cases associated with the novel designer drug 3′,4′‐methylenedioxy‐α‐pyrrolidinohexanophenone and studies on its human metabolism using high‐resolution mass spectrometry	12
Identification of Hypoxia‐inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control	12
Automated online dried blood spot sample preparation and detection of anabolic steroid esters for sports drug testing	12
A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB‐FUBIATA	12
Single hair analysis: Validation of a screening method for over 150 analytes and application on documented single‐dose cases	12
Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services	12
Metabolism of MMB022 and identification of dihydrodiol formation in vitro using synthesized standards	12
β₂‐Adrenoceptor agonist activity of higenamine	11
Is pain temporary and glory forever? Detection of tramadol using dried blood spot in cycling competitions	11
Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material	11
The use of RNA‐based 5'‐aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses	11
The colloidal gold nanoparticle‐based lateral flow immunoassay for fast and simple detection of plant‐derived doping agent, higenamine	11
Potential for dehydration to impact the athlete biological passport	11
Stability of phosphatidylethanol 16:0/18:1 in authentic and spiked whole blood	11
Anabasine‐based measurement of cigarette consumption using wastewater analysis	11
EPO transgene detection in dried blood spots for antidoping application	11
Detection of clenbuterol residues in beef sausages and its enantiomeric analysis using UHPLC–MS/MS: A risk of unintentional doping in sport field	11
Development and validation of a fast ultra‐high‐performance liquid chromatography tandem mass spectrometry method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair	11
Development of an electrochemical flow‐through cell for the fast and easy generation of isotopically labeled metabolite standards	10
Removal of the influence of plasma volume fluctuations for the athlete biological passport and stability of haematological variables in active women taking oral contraception	10
The application of laboratory‐based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation	10
Detection of bioactive peptides including gonadotrophin‐releasing factors (GnRHs) in horse urine using ultra‐high performance liquid chromatography–high resolution mass spectrometry (UHPLC/HRMS)	10
A multi‐parametric approach to remove the influence of plasma volume on the athlete biological passport during a Union Cycliste Internationale cycling stage race	10
Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on‐line solid phase extraction	10
Presence of the ketamine analog of 2‐fluorodeschloroketamine residues in wastewater	10
Liquid chromatography–mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes	10
Monitoring methamphetamine in the United States: A two‐decade review as seen by the DEA methamphetamine profiling program	10
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation	10
Synthesis and determination of analytical characteristics and differentiation of positional isomers in the series of N‐(2‐methoxybenzyl)‐2‐(dimethoxyphenyl)ethanamine using chromatography–mass	10
Advances in the detection of growth hormone releasing hormone synthetic analogs	10
Hematological adaptations and detection of recombinant human erythropoietin combined with chronic hypoxia	10
Stanozolol‐N‐glucuronide metabolites in human urine samples as suitable targets in terms of routine anti‐doping analysis	10
A review of cannabidiol‐containing electronic liquids—Current regulations and labelling accuracy	10
Elimination profiles of prednisone and prednisolone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations	10
Identification of creatine kinase and alpha‐1 antitrypsin as protein targets of alkylation by sulfur mustard	10
Discovery of c.577del in EPO: Investigations into endogenous EPO double‐band detected in blood with SAR‐PAGE	10
A quantitative PCR screening method for adeno‐associated viral vector 2‐mediated gene doping	10
Application of a chiral high‐performance liquid chromatography‐tandem mass spectrometry method for the determination of 13 related amphetamine‐type stimulants to forensic samples: Interpretative hypot	10
Evaluation of blood parameters by linear discriminant models for the detection of testosterone administration	10
Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F‐QMPSB, QMiPSB, and SGT‐233	9
Optimization and implementation of four duplex quantitative polymerase chain reaction assays for gene doping control in horseracing	9
Determination of ethyl glucuronide in human hair samples: Decontamination vs extraction	9
Estimation of alcohol and nicotine consumption in 11 cities of Turkey using wastewater‐based epidemiology	9
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1‐valeroyl‐d‐lysergic acid diethylamide (1V‐LSD)	9
EMCDDA framework and practical guidance for naming synthetic cannabinoids	9
Detection of AP‐237 and synthetic cannabinoids on an infused letter sent to a German prisoner	9
Sensitive screening of synthetic cannabinoids using liquid chromatography quadrupole time‐of‐flight mass spectrometry after solid phase extraction	9
Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13‐year retrospective study	9
Development and validation of a simple online‐SPE method coupled to high‐resolution mass spectrometry for the analysis of stanozolol‐N‐glucuronides in urine samples	9
Meldonium residues in milk: A possible scenario for inadvertent doping in sports?	9
Optimization, validation, and comparison of a rapid method for the quantification of insulin‐like growth factor 1 in serum using liquid chromatography–high‐resolution mass spectrometry	9
Serum concentrations, pharmacokinetic/pharmacodynamic modeling, and effects of dexamethasone on inflammatory mediators following intravenous and oral administration to exercised horses	9
Comparative assessment of electronic nicotine delivery systems aerosol and cigarette smoke on endothelial cell migration: The Replica Project	9
Metabolism of 4F‐MDMB‐BICA in zebrafish by liquid chromatography–high resolution mass spectrometry	9
Pharmacokinetics of freebase nicotine and nicotine salts following subcutaneous administration in male rats	9
Non‐contact detection of fentanyl by a field‐portable ion mobility spectrometer	9
Reliable identification and quantification of anabolic androgenic steroids in dietary supplements by using gas chromatography coupled to triple quadrupole mass spectrometry	9
Orally administered cannabidiol does not produce false‐positive tests for Δ⁹‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000	9
Emergence of the less common cannabinoid Δ⁸‐Tetrahydrocannabinol in a doping sample	9
Human hair tests to document drug environmental contamination: Application in a family law case involving N,N‐dimethyltryptamine	8

Enantiomeric separation and quantification of R/S‐amphetamine in serum using semi‐automated liquid‐liquid extraction and ultra‐high performance supercritical fluid chromatography‐tandem mass spectrome	8
Analytical developments of p‐hydroxy prenylamine reference material for dope control research: Characterization and purity assessment	8
An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile	8
Carbon and nitrogen isotopic analysis of morphine from opium and heroin samples originating in the four major heroin producing regions	8
Detection of follistatin‐based inhibitors of the TGF‐β signaling pathways in serum/plasma by means of LC‐HRMS/MS and Western blotting	8
Low‐copy transgene detection using nested digital polymerase chain reaction for gene‐doping control	8
Detection of undeclared doping substances in nutritional supplements in the context of follow‐up investigations concerning adverse analytical findings	8
Driving license regranting: Hair EtG, serum CDT, and the role of sociodemographic and medicolegal variables	8
Hair testing for acetazolamide as an evidence of the use of a contaminated dietary supplement	8
Investigation of plasma concentrations of paracetamol, metacetamol, and orthocetamol in Japanese racehorses using liquid chromatography–electrospray ionisation–tandem mass spectrometry	8
In vitro studies of hypoxia inducible factor‐prolyl hydroxylase inhibitors daprodustat, desidustat, and vadadustat for equine doping control	8
Separating the wheat from the chaff: Observations on the analysis of lysergamides LSD, MIPLA, and LAMPA	8
Equine metabolism of the selective androgen receptor modulator AC‐262536 in vitro and in urine, plasma and hair following oral administration	8
HepG2 as promising cell‐based model for biosynthesis of long‐term metabolites: Exemplified for metandienone	8
Development of an improved method to estimate the days of continuous drug ingestion, based on the micro‐segmental hair analysis	8
Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow‐up study	8
Determination of amphetamine enantiomers in urine by conductive vial electromembrane extraction and ultra‐high performance supercritical fluid chromatography tandem mass spectrometry	8
An unusual detection of tert‐butyl‐4‐anilinopiperidine‐1‐carboxylate in seizures of falsified ‘Xanax’ tablets and in items in a suspected heroin seizure submitted by Irish law enforcement	8
Illicit drug profiling: A historical perspective	8
No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders	8
In vitro cytoxicity profile of e‐cigarette liquid samples on primary human bronchial epithelial cells	8
New application of the CRISPR‐Cas9 system for site‐specific exogenous gene doping analysis	8
Red blood cell derived extracellular vesicles during the process of autologous blood doping	8
From a non‐targeted metabolomics approach to a targeted biomarkers strategy to highlight testosterone abuse in equine. Illustration of a methodological transfer between platforms and laboratories	8
Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis prot	8
The Society of Hair Testing consensus on general recommendations for hair testing and drugs of abuse testing in hair	8
Detection of clostebol in sports: Accidental doping?	8
Further development of a liquid chromatography–high‐resolution mass spectrometry/mass spectrometry‐based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ric	8
Robustness of digital PCR and real‐time PCR against inhibitors in transgene detection for gene doping control in equestrian sports	8
Detection of pharmaceuticals in “dirty sprite” using gas chromatography and mass spectrometry	7
Detection of LongR³‐IGF‐I, Des(1‐3)‐IGF‐I, and R³‐IGF‐I using immunopurification and high resolution mass spectrometry for antidoping purposes	7
Detection of γ‐hydroxybutyric acid‐related acids in blood plasma and urine: Extending the detection window of an exogenous γ‐hydroxybutyric acid intake?	7
DNA damage in human oral cells induced by use of e‐cigarettes	7
Detection and identification of ACP‐105 and its metabolites in equine urine using LC/MS/MS after oral administration	7
Analytical strategy for the detection of ecdysterone and its metabolites in vivo in uPA(+/+)‐SCID mice with humanized liver, human urine samples, and estimation of prevalence of its use in anti‐doping	7
Application of single hair analysis in a doping case involving amphetamine	7
Development and validation of an analytical method for the simultaneous determination of the alcohol biomarkers ethyl glucuronide, ethyl sulfate, N‐acetyltaurine, and 16:0/18:1‐phosphatidylethanol in	7
Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents	7
Qualitative threshold method validation and uncertainty evaluation: A theoretical framework and application to a 40 analytes liquid chromatography–tandem mass spectrometry method	7
E‐cigarette puffing topography: The importance of assessing user behaviour to inform emissions testing	7
Effective treatment and prevention of attempted suicide, anxiety, and aggressiveness with fluoxetine, despite proven use of androgenic anabolic steroids	7
Air monitoring for synthetic cannabinoids in a UK prison: Application of personal air sampling and fixed sequential sampling with thermal desorption two‐dimensional gas chromatography coupled to time‐	7
Re‐evaluation of combined ((ES/EG)/(TS/TG)) ratio as a marker of testosterone intake in men	7
Determination of drugs in exhumed liver and brain tissue after over 9 years of burial by liquid chromatography–tandem mass spectrometry—Part 2: Benzodiazepines, opioids, and further drugs	7
Identification of equine in vitro metabolites of seven non‐steroidal selective androgen receptor modulators for doping control purposes	7
Excretion of 19‐norandrosterone after consumption of boar meat	7
Doping detection in animals: A review of analytical methodologies published from 1990 to 2019	7
Elimination profiles of betamethasone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations	7
Risk of unintentional antidoping rule violations by consumption of hemp products	7
Quantification of hordenine in a complex plant matrix by direct analysis in real time–high‐resolution mass spectrometry: Application to the “plant of concern” Sceletium tortuosum	7
PEth 16:0/18:1 and 16:0/18:2 after consumption of low doses of alcohol—A contribution to cutoff discussion	6
Implementation of the HIF activator IOX‐2 in routine doping controls – Pilot study data	6
Metabolic studies of selective androgen receptor modulators RAD140 and S‐23 in horses	6
Tentative identification of the phase I and II metabolites of two synthetic cathinones, MDPHP and α‐PBP, in human urine	6
Postmortem metabolomics: Correlating time‐dependent concentration changes of xenobiotic and endogenous compounds	6
Investigations in carbon isotope ratios of seized testosterone and boldenone preparations	6
Pharmacokinetics of salmeterol and its main metabolite α‐hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance‐trained men: Implications for doping control	6
Structure elucidation of the novel synthetic cannabinoid Cumyl‐Tosyl‐Indazole‐3‐Carboxamide (Cumyl‐TsINACA) found in illicit products in Germany	6
Sexually transmitted doping: The impact of urine contamination of semen	6
Operation of the anti‐doping laboratory for the Beijing 2022 Olympic and Paralympic Winter Games	6
Differentiation of boldenone administration from ex vivo transformation in the urine of castrated male horses	6
Long‐term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometry fo	6
Label‐free proteomics for discovering biomarker candidates of RAD140 administration to castrated horses	6
Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration	6
The intra‐individual stability of GH biomarkers IGF‐I and P‐III‐NP in relation to GHRH administration, menstrual cycle, and hematological parameters	6
Carbon isotopic characterization of prednisolone and prednisone pharmaceutical formulations: Implications in antidoping analysis	6
Trace residue identification, characterization, and longitudinal monitoring of the novel synthetic opioid β‐U10, from discarded drug paraphernalia	6
Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P‐AL‐LAD	6
A SERS quenching method for the sensitive determination of insulin	6
The effect of creatine ingestion on urinary creatinine concentration: Does supplementation mask a heavy dilution?	6
Modified congener analysis: Quantification of cyanide in whole blood, other body fluids, and diverse beverages	6
The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS	6
In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis	6
miRNAs detection in equine plasma by quantitative polymerase chain reaction for doping control: Assessment of blood sampling and study of eca‐miR‐144 as potential erythropoiesis stimulating agent biom	6
Synthesis and characterization of high‐purity N,N‐dimethyltryptamine hemifumarate for human clinical trials	6
Real‐time electrochemical screening of cocaine in lab and field settings with automatic result generation	6
Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometer for the purpose of doping control	6
Finding the proverbial needle: Non‐targeted screening of synthetic opioids in equine plasma	6
Long‐term stability study and evaluation of intact steroid conjugate ratios after the administration of endogenous steroids	6
Human abuse liability assessment of e‐cigarettes: Why, what and how?	6
In vitro and in vivo metabolism and detection of 3‐HO‐PCP, a synthetic phencyclidine, in human samples and pooled human hepatocytes using high resolution mass spectrometry	6
Characterization of new psychoactive substances by integrating benchtop NMR to multi‐technique databases	6
Annual banned‐substance review—Analytical approaches in human sports drug testing 2021/2022–	6
A novel high‐performance liquid chromatography with diode array detector method for the simultaneous quantification of the enzyme‐reactivating oximes obidoxime, pralidoxime, and HI‐6 in human plasma	6
Genetic individual identification from dried urine spots: A complementary tool to drug monitoring and anti‐doping testing	6
Detection of insulin analogues and large peptides >2 kDa in urine	6
Hair testing applied to the assessment of in utero exposure to drugs: Critical analysis of 51 cases of the University Hospital of Verona	6
Feasibility of microvolumetric capillary whole blood collections for usage in Athlete Biological Passport analysis	6
An optimized SDS‐PAGE protocol with a new blotting system for the initial testing procedure of ESAs in doping control	6
Hair analysis for beta‐blockers and calcium‐channel blockers by using liquid chromatography‐tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy	6
Development and validation of a color spot test method for the presumptive detection of 25‐NBOMe compounds	6
Metabolism of third generation synthetic cannabinoids using zebrafish larvae	6
Comparison of in vitro and in vivo models for the elucidation of metabolic patterns of 7‐azaindole‐derived synthetic cannabinoids exemplified using cumyl‐5F‐P7AICA	6
Use of liquid chromatography‐tandem mass spectrometry for determination of higenamine in urine following oral administration of traditional Chinese medicine	6
Development and validation of a fast gas chromatography combustion isotope ratio mass spectrometry method for the detection of epiandrosterone sulfate in urine	6